Atlas Trials

Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus

Clinical trial NCT03618862 · COMPLETED

Trial details

NCT number
NCT03618862
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Hiv
Start date
2019-01-18
Primary completion
2021-07-16
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.